- Oncologist Dr Harold Burstein said: ‘We are in a golden age of cancer treatment’
- Results on cancer drugs were shared at American Society For Clinical Oncology
- Studies on immunotherapy drugs show patients living longer and healthier lives
- Some pills, available on the NHS, have stopped tumour growth in cancer patients
Avacta Group Plc (LON:AVCT) offers reagents and therapeutics based on Affimer technology for diagnostic and research applications in the United Kingdom. The company’s custom Affimer products are also used in drugs and biomarkers discovery in biotech research and development.